| P50 | author | Leonard H Wexler | Q89890364 |
| | Kevin C. Oeffinger | Q98166561 |
| | Chaya S Moskowitz | Q100738671 |
| | Paul Meyers | Q37828974 |
| | Suzanne L Wolden | Q41644503 |
| P2093 | author name string | Joanne F Chou | |
| | Heather Magnan | |
| | Alexander J Chou | |
| | Danielle Novetsky Friedman | |
| | Roberto Adsuar | |
| | Katherine Chastain | |
| | Amelia DeRosa | |
| | Joanne Candela | |
| | Shawn Pun | |
| | Tamara Kahan | |
| P2860 | cites work | High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors | Q50866450 |
| | Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease | Q53460488 |
| | Second solid cancers after radiation therapy: a systematic review of the epidemiologic studies of the radiation dose-response relationship | Q26996120 |
| | 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines | Q29620107 |
| | Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data. | Q31157886 |
| | Late recurrence in pediatric cancer: a report from the Childhood Cancer Survivor Study | Q33567577 |
| | Long-term survivors of childhood Ewing sarcoma: report from the childhood cancer survivor study | Q34169663 |
| | Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients: the Italian Sarcoma Group Experience (1983-2006). | Q34636631 |
| | Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study | Q34835391 |
| | Second cancers in survivors of childhood cancer | Q35084794 |
| | Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group | Q35615792 |
| | Ifosfamide dose-intensification for patients with metastatic Ewing sarcoma | Q35760189 |
| | Long-term adverse outcomes in survivors of childhood bone sarcoma: the British Childhood Cancer Survivor Study. | Q36086856 |
| | Age, Tumor Characteristics, and Treatment Regimen as Event Predictors in Ewing: A Children's Oncology Group Report. | Q36174379 |
| | Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group | Q36389207 |
| | Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction. | Q36511753 |
| | Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials | Q36589635 |
| | Second cancers in patients with the Ewing sarcoma family of tumours | Q36711750 |
| | Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies | Q36849432 |
| | Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study. | Q36914353 |
| | Radiation-Related New Primary Solid Cancers in the Childhood Cancer Survivor Study: Comparative Radiation Dose Response and Modification of Treatment Effects. | Q37231338 |
| | Identification of Discrete Prognostic Groups in Ewing Sarcoma | Q37232948 |
| | Ewing Sarcoma: Current Management and Future Approaches Through Collaboration | Q38573422 |
| | Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks | Q40761813 |
| | Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas | Q42525574 |
| | Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease | Q43878525 |
| | Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone | Q44320806 |
| | Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group | Q44557261 |
| | Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage | Q44558058 |
| | Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults. | Q44583963 |
| P577 | publication date | 2017-04-18 | |
| P1433 | published in | Pediatric Blood & Cancer | Q15754342 |
| P1476 | title | Morbidity and mortality after treatment of Ewing sarcoma: A single-institution experience | |